I think it is because of the challenge model they're using in this trial, with only Walter Reed and SUNY experienced with the model. It might not gain ethics approval in AUS.
I also thought they had to apply for an IND through the FDA, not sure how that's going.
Ann: ISLA-101 Phase 2a clinical trial update, page-38
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ILA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.020(12.5%) |
Mkt cap ! $28.06M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 19.5¢ | 17.3¢ | $104.3K | 571.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 105309 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 53012 | 2 |
View Market Depth
| Last trade - 15.47pm 13/11/2024 (20 minute delay) ? |
| ILA (ASX) Chart |